Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
By Arija Maat, Annemarie Fouwels, Lieuwe de Haan
-
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
By Georgia Trakada, MD, Pashalis Steiropoulos, MD, and Demosthenes Bouros, MD, FCCP
-
EVIDENCE-BASED MEDICINE
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
By Michael E. Thase, MD
-
ORIGINAL RESEARCHAddressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
By Ilya Lipkovich, PhD, Craig H. Mallinckrodt, PhD, Apurva Prakash, BA, and Andrew A. Nierenberg, MD
-
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
By Alisa B. Busch, MD, MS, Richard G. Frank, PhD, and Gary Sachs, MD
-
ORIGINAL RESEARCHCriteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
By Prakash S. Masand, MD, James Eudicone, MS, Andrei Pikalov, MD, PhD, Robert D. McQuade, PhD, Ronald N. Marcus, MD, Estelle Vester-Blokland, MD and Berit X. Carlson, PhD
-
Letter to the Editor
AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
-
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY -
LETTER TO THE EDITOR
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC
-
ORIGINAL RESEARCHClinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
By Mark A. Demitrack, Michael E. Thase
-
COMPLICATED CASE HISTORIES
Hypomania Induced by Escitalopram: 2 Case Reports
By Ravi C. Sharma
-
EVIDENCE-BASED MEDICINE
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luck
-
DRUG INTERACTIONS
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
By Aram Oganesian, Adam D. Shilling, Ruth Young-Sciame, Judy Tran, Adiba Watanyar, Farooq Azam, John Kao, Louis Leung
-
ORIGINAL RESEARCHStatistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
By Andrew C. Leon
-
COMPLICATED CASE HISTORIES
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
By Omer Saatcioglu, Sevda Gumus, Kirkor Kamberyan, Medaim Yanik
-
COMPLICATED CASE HISTORIES
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
By Samir Kumar Praharaj, Sujit Sarkhel, Roshan Vitthalrao Khanande, Vinod Kumar Sinha
-
COMPLICATED CASE HISTORIES
Antidepressant Induced Apathy Responsive to Dose Reduction
By Sreekant Kodela, Pavan Dontineni Venkata
-
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder:
A 12-week, Double-Blind, Placebo-Controlled Pilot Study
Zuowei Wang, Keming Gao, David E. Kemp, Philip K. Chan, Mary Beth Serrano, Carla Conroy, Yiru Fang, Stephen J. Ganocy, Robert L. Findling, Joseph R. Calabrese
-
NEGATIVE AND FAILED CLINICAL TRIAL RESULTS
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
By Andrew J. Cutler, Tram Tran-Johnson, Amir Kalali, Mikael Åström, Martin Brecher, Didier Meulien
